Emblem Corp Stock

Stocks

EMC

CA29082J1084

Pharmaceuticals

End-of-day quote Toronto S.E. 15:59:45 2019-03-18 EDT 5-day change 1st Jan Change
1.880 CAD +1.62% Intraday chart for Emblem Corp +1.62% +106.59%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Emblem Corp

Market Cap 248M 216M 199M 186M 348M 23.78B 355M 2.37B 917M 11.46B 932M 912M 39.85B P/E Ratio 2017
-16.3x
P/E Ratio 2018 -4.48x
Enterprise Value 219M 190M 175M 164M 307M 21B 313M 2.09B 810M 10.12B 823M 805M 35.19B EV / Sales 2017
72,352,077x
EV / Sales 2018 10,915,686x
Free-Float
98.36%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Chief Executive Officer - 2017-11-30
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 44 -
Director/Board Member - 2018-11-05
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.62%+1.62% - - 0
+0.82%+4.01%-11.30%-3.81% 13.31B
-1.10%-2.21%-35.37%-56.82% 4.92B
-0.22%+2.94%-9.20%-2.82% 4.74B
-1.86%-5.35%+8.38%-21.79% 3.78B
-1.61%+0.40%+2.70%-43.28% 3.76B
-2.69%-4.14%-5.21%-10.76% 3.59B
-0.91%+1.00%-13.63%-5.90% 3.13B
-1.50%-2.43%-13.60%-32.08% 2.25B
-6.14%-3.41%-15.13%+24.40% 1.72B
Average -1.36%-1.69%-10.26%-16.98% 4.12B
Weighted average by Cap. -0.85%-0.51%-10.78%-16.41%

Financials

2017 2018
Net sales 2.69 2.34 2.15 2.02 3.77 257.95 3.85 25.71 9.95 124.34 10.11 9.9 432.34 8.22 7.14 6.58 6.16 11.52 787.36 11.76 78.47 30.38 379.53 30.87 30.2 1.32K
Net income -12.1M -10.5M -9.68M -9.07M -16.95M -1.16B -17.3M -115M -44.71M -559M -45.43M -44.45M -1.94B -24.26M -21.05M -19.41M -18.18M -33.97M -2.32B -34.68M -231M -89.62M -1.12B -91.07M -89.11M -3.89B
Net Debt -21.51M -18.67M -17.21M -16.12M -30.13M -2.06B -30.75M -205M -79.47M -993M -80.76M -79.02M -3.45B -29.05M -25.21M -23.24M -21.78M -40.69M -2.78B -41.53M -277M -107M -1.34B -109M -107M -4.66B
Logo Emblem Corp
Emblem Corp is a Canada-based Company engaged in alternative medicine sector. The Company is producer and distributor of medical cannabis and cannabis derivatives licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates in one segment, the production and sale of medical cannabis to patients who have received medical authorizations to acquire and use cannabis. The Company offers fully integrated services covering the full cannabis spectrum, from growing to selling, as well as educating and also creating new forms of cannabinoid-based medication in standardized dosages. All of the Company’s assets are located in Canada.
Employees
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!